HLN — HALEON News Story

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapNeutral

Market Cap
$39.87bn
Enterprise Value
$49.71bn
Revenue
£11.03bn

All News

Director/PDMR Shareholding

HALEON

26/09/2025 13:30

RNS Number : 0535B

Haleon PLC

26 September 2025

 

 

Haleon plc: Director/PDMR Shareholding 

 

26 September 2025: Haleon plc (the "Company" or "Haleon") (LSE/NYSE:HLN) today announces notification and public disclosure in accordance with the requirements of The UK Market Abuse Regulation of Transactions by Persons Discharging Managerial Responsibilities ("PDMRs").

 

On 25 September 2025, the Company was notified of the following transactions as detailed below.

 

1 Details of the person discharging managerial responsibilities / person closely associated
a) Name Dawn Allen
2 Reason for the notification
a) Position/status Chief Financial Officer - PDMR
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Haleon plc
b) LEI 549300PSB3WWEODCUP19
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument
Identification code Ordinary Shares of £0.01 each
GB00BMX86B70
b) Nature of the transaction Acquisition of Ordinary Shares as a result of dividend reinvestment
c) Price(s) and volume(s) 
Price(s) Volume(s) 
£3.31963 1186.71154 
d) Aggregated information N/A
- Aggregated volume 
- Price 
e) Date of the transaction 23 September 2025
f) Place of the transaction London Stock Exchange (XLON)

 

 

1 Details of the person discharging managerial responsibilities / person closely associated 
a) Name Keith Choy 
2 Reason for the notification 
a) Position/status President, Asia Pacific - PDMR 
b) Initial notification /Amendment Initial Notification 
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 
a) Name Haleon plc 
b) LEI 549300PSB3WWEODCUP19 
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted 
a) Description of the financial instrument, type of instrument Ordinary Shares of £0.01 each
Identification code GB00BMX86B70 
b) Nature of the transaction Acquisition of Ordinary Shares as a result of dividend reinvestment 
c) Price(s) and volume(s) 
Price(s) Volume(s) 
£3.31963 3749.41677 
d) Aggregated information N/A 
- Aggregated volume 
- Price 
e) Date of the transaction 23 September 2025 
f) Place of the transaction London Stock Exchange (XLON) 

 

 

1 Details of the person discharging managerial responsibilities / person closely associated
a) Name Filippo Lanzi
2 Reason for the notification
a) Position/status President, EMEA and LATAM - PDMR
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Haleon plc
b) LEI 549300PSB3WWEODCUP19
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument
Identification code Ordinary Shares of £0.01 each
GB00BMX86B70
b) Nature of the transaction Acquisition of Ordinary Shares as a result of dividend reinvestment
c) Price(s) and volume(s) 
Price(s) Volume(s) 
£3.31963 2356.42498 
d) Aggregated information N/A
- Aggregated volume 
- Price 
e) Date of the transaction 23 September 2025
f) Place of the transaction London Stock Exchange (XLON)

 

 

1 Details of the person discharging managerial responsibilities / person closely associated 
a) Name Brian McNamara 
2 Reason for the notification 
a) Position/status Chief Executive Officer - PDMR 
b) Initial notification /Amendment Initial Notification 
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 
a) Name Haleon plc 
b) LEI 549300PSB3WWEODCUP19 
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted 
a) Description of the financial instrument, type of instrument
Identification code Ordinary Shares of £0.01 each
GB00BMX86B70 
b) Nature of the transaction Acquisition of Ordinary Shares as a result of dividend reinvestment 
c) Price(s) and volume(s) 
Price(s) Volume(s) 
£3.31963 5693.56923 
d) Aggregated information N/A 
- Aggregated volume 
- Price 
e) Date of the transaction 23 September 2025 
f) Place of the transaction London Stock Exchange (XLON)
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument
Identification code Haleon plc American Depositary Shares (ADS)
US4055521003
b) Nature of the transaction Acquisition of ADSsas a result of dividend reinvestment
c) Price(s) and volume(s) 
Price(s) Volume(s) 
$8.99986 2026.50806 
d) Aggregated information N/A
- Aggregated volume 
- Price 
e) Date of the transaction 23 September 2025
f) Place of the transaction New York Stock Exchange (XNYS)


 

 

 

1 Details of the person discharging managerial responsibilities / person closely associated
a) Name Edward Petter
2 Reason for the notification
a) Position/status Chief Corporate Affairs Officer - PDMR
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Haleon plc
b) LEI 549300PSB3WWEODCUP19
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument
Identification code Ordinary Shares of £0.01 each
GB00BMX86B70
b) Nature of the transaction Acquisition of Ordinary Shares as a result of dividend reinvestment
c) Price(s) and volume(s) 
Price(s) Volume(s) 
£3.31963 576.54018 
d) Aggregated information N/A
- Aggregated volume 
- Price 
e) Date of the transaction 23 September 2025
f) Place of the transaction London Stock Exchange (XLON)

 

 

1 Details of the person discharging managerial responsibilities / person closely associated 
a) Name Tamara Rogers 
2 Reason for the notification 
a) Position/status Chief Marketing Officer - PDMR 
b) Initial notification /Amendment Initial Notification 
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 
a) Name Haleon plc 
b) LEI 549300PSB3WWEODCUP19 
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted 
a) Description of the financial instrument, type of instrument
Identification code Ordinary Shares of £0.01 each
GB00BMX86B70 
b) Nature of the transaction Acquisition of Ordinary Shares as a result of dividend reinvestment 
c) Price(s) and volume(s) 
Price(s) Volume(s) 
£3.31963 1906.13339 
d) Aggregated information N/A
- Aggregated volume 
- Price 
e) Date of the transaction 23 September 2025
f) Place of the transaction London Stock Exchange (XLON) 


 

Amanda Mellor

Company Secretary

 

About Haleon

Haleon (LSE/NYSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon's product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Its long-standing brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are built on trusted science, innovation and deep human understanding.

 

For more information, please visit www.haleon.com. 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
DSHBBGDCXUDDGUL

HLN — HALEON News Story

Director/PDMR Shareholding

Recent news on HALEON

Brief: Haleon Issues Voluntary Recall Of Gas-X Extra Strength Softgels 125 MG, 120 CT & 72 CT

Director/PDMR Shareholding

Director/PDMR Shareholding

Europe Research Roundup: Burberry, Hochtief, Volex

UK's Haleon falls after quarterly revenue miss

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Dawn Allen
2	Reason for the notification
a)	Position/status	Chief Financial Officer - PDMR
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Haleon plc
b)	LEI	549300PSB3WWEODCUP19
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary Shares of £0.01 each GB00BMX86B70
b)	Nature of the transaction	Acquisition of Ordinary Shares as a result of dividend reinvestment
c)	Price(s) and volume(s)
			Price(s)	Volume(s)
			£3.31963	1186.71154

d)	Aggregated information	N/A

	- Aggregated volume

	- Price

e)	Date of the transaction	23 September 2025
f)	Place of the transaction	London Stock Exchange (XLON)

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Keith Choy
2	Reason for the notification
a)	Position/status	President, Asia Pacific - PDMR
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Haleon plc
b)	LEI	549300PSB3WWEODCUP19
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary Shares of £0.01 each

	Identification code	GB00BMX86B70

b)	Nature of the transaction	Acquisition of Ordinary Shares as a result of dividend reinvestment
c)	Price(s) and volume(s)
			Price(s)	Volume(s)
			£3.31963	3749.41677

d)	Aggregated information	N/A

	- Aggregated volume

	- Price

e)	Date of the transaction	23 September 2025
f)	Place of the transaction	London Stock Exchange (XLON)

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Filippo Lanzi
2	Reason for the notification
a)	Position/status	President, EMEA and LATAM - PDMR
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Haleon plc
b)	LEI	549300PSB3WWEODCUP19
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary Shares of £0.01 each GB00BMX86B70
b)	Nature of the transaction	Acquisition of Ordinary Shares as a result of dividend reinvestment
c)	Price(s) and volume(s)
			Price(s)	Volume(s)
			£3.31963	2356.42498

d)	Aggregated information	N/A

	- Aggregated volume

	- Price

e)	Date of the transaction	23 September 2025
f)	Place of the transaction	London Stock Exchange (XLON)

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Edward Petter
2	Reason for the notification
a)	Position/status	Chief Corporate Affairs Officer - PDMR
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Haleon plc
b)	LEI	549300PSB3WWEODCUP19
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary Shares of £0.01 each GB00BMX86B70
b)	Nature of the transaction	Acquisition of Ordinary Shares as a result of dividend reinvestment
c)	Price(s) and volume(s)
			Price(s)	Volume(s)
			£3.31963	576.54018

d)	Aggregated information	N/A

	- Aggregated volume

	- Price

e)	Date of the transaction	23 September 2025
f)	Place of the transaction	London Stock Exchange (XLON)

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Tamara Rogers
2	Reason for the notification
a)	Position/status	Chief Marketing Officer - PDMR
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Haleon plc
b)	LEI	549300PSB3WWEODCUP19
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary Shares of £0.01 each GB00BMX86B70
b)	Nature of the transaction	Acquisition of Ordinary Shares as a result of dividend reinvestment
c)	Price(s) and volume(s)
			Price(s)	Volume(s)
			£3.31963	1906.13339

d)	Aggregated information	N/A

	- Aggregated volume

	- Price

e)	Date of the transaction	23 September 2025
f)	Place of the transaction	London Stock Exchange (XLON)